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Diet and diabetes
iabetes mellitus is expected to be the leading cause of 
chronic disease in Australia by 2023. Being overweight 
or obese carries significant risks for developing type 2 
diabetes mellitus (T2DM). Lifestyle modification remains the 
bedrock of management of T2DM and its related comorbidities 
in Australian and international treatment guidelines.1,2 Once 
T2DM develops, the combination of diet, lifestyle changes and 
physical activity has a major impact on glycaemic control, weight 
management and complication prevention. 
The role of diet in diabetes prevention 
It is estimated that 16.4% of Australians have prediabetes.3 
This is defined as impaired fasting glucose (IFG) and impaired 
glucose tolerance, or an HbA1c of 6.0–6.4% (42– 46 mmol/
mol).4 Prediabetes carries an independent risk for cardiovascular 
disease, separate from the risks of developing T2DM.3  Thus, 
prediabetes risk prevention must address the prevention 
of cardiovascular risks as much as managing progressive 
dysglycaemia.3 
Most diabetes prevention studies (Table 1) included dietary 
components to the intervention. Changes in levels of physical 
activity and, in some cases, addition of pharmacological 
interventions, make it difficult to define the independent 
effect of dietary changes in the prevention of type 2 diabetes.5 
However, of the dietary changes used in these studies, the 
Finnish Diabetes Prevention Study6 gives some insights. Rates of 
diabetes risk reduction were highest in people who achieved the 
greatest adherence to: 
• weight reduction >5% 
• fat intake <30% of total energy intake 
• saturated fat intake <10% of total energy intake 
• dietary fibre intake ≥15 g/1000 kcal 
• at least moderate intensity exercise for >4 hours weekly.
Background
Guidelines for the prevention and management of type 2 
diabetes mellitus (T2DM) reinforce lifestyle management, yet 
advice to guide general practitioners on principles around 
dietary choices is needed. 
Objective
This article provides current evidence regarding the differing 
diets in diabetes prevention and management once T2DM 
arises, including the role in management of complications such 
as hypoglycaemia. 
Discussion
Diets should incorporate weight maintenance or loss, while 
complementing changes in physical activity to optimise 
the metabolic effects of dietary advice. Using a structured, 
team-care approach supports pragmatic and sustainable 
individualised plans, while incorporating current evidence-
based dietary approaches. 
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From the intervention over 6 years, the relative risk reduction 
in progression to diabetes was 31% in the diet group, 46% in the 
exercise group and 42% in the combination group, suggesting 
that an appropriate strategy of physical activity and/or dietary 
changes aimed at promoting weight loss can prevent diabetes. 
It is estimated that weight loss of 5 kg in all people who are 
overweight or obese would reduce the national prevalence of 
T2DM by 15%.7 
When dietary saturated fats are decreased and replaced 
by polyunsaturated fatty acids (PUFAs) there are significant 
reductions in the risks of developing diabetes.8 Additionally, 
a recent study analysing the independent effect of the 
Mediterranean diet on prediabetes development9 showed that 
this diet supplemented with extra virgin olive oil reduced the 
development of prediabetes by 40%, compared with a control 
diet.
The National Health and Medical Research Council (NHMRC) 
Australian Dietary Guidelines 20137 assesses the effects of diet 
on diabetes prevention. Consumption of sugar-sweetened drinks 
increases the risk of developing T2DM. Consumption of cereal 
foods (especially three serves a day of wholegrains) is associated 
with reduced risk of T2DM. This evidence supports three serves 
per day of wholegrain foods conferring a risk reduction of 
21–42%. In some people, consumption of four cups of coffee per 
day reduces the risk of diabetes through unknown mechanisms. 
Two to four serves of dairy foods (milk, cheese, yoghurt) per 
day is associated with reduced risk of metabolic syndrome and 
consumption of at least 1.5 serves of milk, cheese and yoghurt 
per day is associated with reduced risk of T2DM. 
Cardiovascular risk reduction is imperative in prediabetes 
and, as such, the Mediterranean diet seems to have the best 
overall evidence of long-term effects on cardiovascular risk 
reduction.8,10–14
Dietary management when patients 
develop T2DM 
The most successful nutritional strategy for prevention and 
treatment of T2DM is one that is individualised, that takes into 
consideration culture, food availability and personal preferences, 
but follows recommendations that encourage a variety of foods 
from the five main food groups each day. Australian guidelines7 
give similar advice for diabetes prevention, recommending that 
saturated fats should be minimised. Conversely, dietary fat 
quantity or quality has minimal direct influence on glycaemic 
control but may contribute to metabolic effects such as weight 
gain and obesity, which may affect glycaemic control in the longer 
term. 
Extreme dietary restriction and avoidance of certain food 
groups, such as very low dairy or grain-free diets, might achieve 
short-term weight loss but do not represent a sustainable 
balanced diet plan. Ideally, the diet should be sustainable and be 
able to be maintained over the long term to provide adequate 
amounts of nutrients and kilojoules to maintain ideal weight, help 
stabilise blood glucose levels and assist in the maintenance of an 
optimal lipid profile.
Dietary advice should address intake of fruit and vegetables, 
unrefined grains with natural high-fibre content, vegetable 
oils with low content of saturated fat (such as olive oil), nuts, 
legumes, low-fat dairy and fish as sources of protein, and limit the 
intake of highly processed foods.15
Weight management should be a priority, particularly visceral 
fat reduction, in those who are overweight or obese. Visceral 
Table 1. A summary of diabetes prevention studies
Study Number of 
participants
Intervention Treatment Risk reduction
Da Qing IGT and Diabetes 
Study27
577 Diet and exercise 6 years, 
follow-up at 20 years 
34–69%
Finnish Diabetes Prevention 
Study6
522 Diet and exercise 3 years, 
follow-up at 7 years
58%
Diabetes Prevention 
Program28
3234 Diet, exercise and 
metformin 
2.8 years, 
follow-up at 10 years
31–58%
Indian Diabetes Prevention 
Programme29
531 Diet, exercise and 
metformin
3 years 26.4–28.4%
Predimed9 3541 Mediterranean diet  
with:
• EVOO*
• nuts versus control  
diet
4 years • 40% 
• 18% 
Prediabetes as a 
secondary endpoint
*EVOO, extra virgin olive oil
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adiposity (and its accompanying inflammatory processes) 
contributes to significantly increased insulin resistance and 
complication progression. 
Physical activity acts independently and synergistically with 
attempts to control weight regain achieved through nutritional 
interventions. Total reduction of kilojoule intake achieves this aim, 
independently of the macronutrient component of the diet. 
The NHMRC Australian Dietary Guidelines 2013 has a pictorial 
guide to assist with the education of patients. 
Guiding patients to make a choice
Use of the 5As approach (Ask, Assess, Advise, Assist and 
Arrange),16,17 will allow the general practitioner (GP) to adopt 
a plan that considers individual, cultural and lifestyle factors in 
guiding food choices, using a team-based approach to dietary 
support, including the use of a dietician, exercise physiologist and 
specialist care services (eg for a very low energy diet or bariatric 
surgery pre- and post-surgical care). These principles are further 
explained in the Royal Australian College of General Practitioners’ 
Smoking, nutrition, alcohol, physical activity (SNAP) guidelines.17 
Various popular dietary approaches
Mediterranean diet 
A Mediterranean diet is one that comprises at least two of the 
following components:13
• high monounsaturated:saturated fat ratio
• low-to-moderate red wine consumption
• high consumption of legumes
• high consumption of grains and cereals
• high consumption of fruits and vegetables
• low consumption of meat and meat products and increased 
consumption of fish
• moderate consumption of milk and dairy products. 
A kilojoule-reduced Mediterranean diet may achieve weight 
loss and may show improvement in blood pressure control and 
triglyceride levels. The benefit of a Mediterranean diet is that it is 
flexible and can suit a vegan, vegetarian or meat-eater. 
Low carbohydrate diets 
These diets have different descriptions in clinical trials, making 
broad judgments of their effectiveness difficult. Examples include:
• low-carbohydrate ketogenic diet (LCKD): <50 g of 
carbohydrates (10% kilojoules) daily
• low-carbohydrate diet (LCD): 50–130 g carbohydrates (10–26% 
of kilojoules) daily 
• moderate carbohydrate diet (MCD): 130–225g carbs daily 
(26–45% of kilojoules) daily.
Across this range, however, the effects on improved 
glycaemia and weight reduction may be mainly due to kilojoule 
restriction.18–20 Longer term studies have not revealed any 
prolonged superiority of these diets in complication risk reduction 
and short-term studies have not revealed any risk increase.19,20
Intermittent or alternate day fasting versus 
continual calorie restriction (CCR) 
Despite the popularity of the 5:2 diet, a review21 has found no 
meaningful differences in glucose control. There was more 
weight loss with CCR but each diet produced comparable 
reductions in visceral fat weight. The authors concluded that 
more research is needed to see if there are benefits specific 
to T2DM. Significantly, fasting may need careful assessment 
to avoid hypoglycaemia in patients on oral sulphonylureas or 
insulins. 
Very low energy diets (VLED) 
Very low-energy diets may be a useful intensive intervention that 
is effective in achieving weight loss. According to the NHMRC 
guidelines,16 VLED may be considered in adults with a BMI 
>30 kg/m2, or with a BMI >27 kg/m2 and T2DM. Rather than 
self-management, referral to specialist care services would be 
recommended for this approach. 
Low glycaemic index diet 
The effect of foods with a low glycaemic index has been 
studied in T2DM22 and there is some evidence for benefit 
through a reduction in HbA1c levels of up to 0.5% and fewer 
hypoglycaemic events. However, this dietary approach did not 
achieve additional weight loss, compared with high glycaemic 
index or load diets. 
Alcohol
Given the additive effects of alcohol and hypoglycaemia on 
behaviour and cognitive function, it is recommended that people 
with diabetes not consume alcohol when driving. Alcohol may 
aggravate accompanying comorbidities, including liver disease 
and neuropathy – so adherence to the Australian Alcohol 
guidelines23 is advisable, as is discussion with the diabetes health 
professional team members. 
Low kilojoule sweeteners
A meta-analysis of multiple trials24 showed a small amount of 
weight loss with the use of low-kilojoule sweeteners. Use of 
such sweeteners could be helpful for weight maintenance for 
patients with T2DM, but there is a lack of evidence that they may 
assist in preventing complications of T2DM.
Patients using insulin 
The total carbohydrate intake at a meal correlates closely with 
postprandial glycaemia, but improving glycaemic control by 
limiting the carbohydrate intake alone has not been supported 
by high-quality studies.25 However, understanding the patterns of 
carbohydrate consumption and self-monitoring of blood glucose 
(SMBG) may be helpful for patients using mealtime or prandial 
rapid-acting insulin, as suggested in UK guidelines.25 In patients 
with unstable T2DM on insulin, the use of low carbohydrate 
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dietary approaches, including ketogenic diets, may cause 
hypoglycaemia, complicating the matching of glucose self-
monitoring to medical supervision of insulin dose adjustment. 
Diet and hypoglycaemia1
If the blood glucose levels (BGL) is <4.0 mmol/L and the patient 
is symptomatic, awake and can swallow, manage according to 
the Rule of 15:1
• Provide 15 g of quick-acting carbohydrate that is easy to 
consume (eg half a can of regular (non-diet) soft drink, half 
a glass of fruit juice, 3 teaspoons of sugar or honey, 6–7 
jellybeans, 3 glucose tablets).
• Wait 15 minutes and repeat blood glucose check. If the level 
is not rising, suggest eating another quick-acting carbohydrate 
from the above list.
• If the patient’s next meal is more than 15 minutes away, 
provide some longer acting carbohydrate (eg a sandwich, 
1 glass of milk or soy milk, 1 piece of fruit, 2–3 pieces of 
dried apricots, figs or other dried fruit, 1 tub of natural low-fat 
yoghurt, 6 small dry biscuits and cheese).
• Test glucose again during the next 2–4 hours.
Diet and nephropathy 
A meta-analysis26 of 13 randomised trials involving 779 
patients showed some evidence that a lowered protein diet 
assisted with diabetic nephropathy, when patients adhered 
to this diet. Management of hypertension through the use 
of pharmacotherapy and a sodium restricted diet, in addition 
to tight glycaemic and lipid control underpin the long-term 
prevention of this condition. 
Summary 
What is the ideal diet for prevention and the management of 
T2DM? It remains an individualised, sustainable dietary plan 
that achieves and maintains an ideal weight range, while 
addressing major comorbidities such as cardiovascular disease. 
Differing dietary approaches to kilojoule restriction, (including 
VLED approaches) act synergistically with increasing physical 
activity to help address weight management. Of all approaches, 
the Mediterranean diet has accumulated evidence showing 
cardiovascular risk reduction. Implementing a structured approach 
using a 5As, team-based approach will allow a GP to provide a 
supportive framework to integrate these principles to support the 
increasing number of identified patients needing dietary advice. 
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